A wide range of targets are currently under investigation for the treatment of cancer. One of the most exciting developments is the utilisation of the patient’s own immune system to treat disease. Greg Bannish of Envigo discusses how Checkpoint inhibitors, which work by removing a layer of endogenous control from normal immune function, effectively “release the brakes” of the immune system and are one such especially promising area of research.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/10/Treating-cancer-by-taking-the-brakes-off.pdf” width=”100%” height=”900px” style=”border:0;”]